INmune Bio partners with Quantum Computing Inc. to apply quantum optimization, AI in Alzheimer’s drug research
Bitget2026/10/14 12:45- INmune Bio entered a collaboration with Quantum Computing to apply quantum computing, AI, and analytics to expand research on XPro1595.
- Work will use QCi’s Dirac-3S quantum optimization machine with clinical and public datasets to identify new indications and biomarkers.
- Partnership targets diseases with biology aligned to XPro’s selective inhibition of soluble TNF, aiming to prioritize candidates with higher success odds.
- Stage 1 marks QCi’s first commercial pharma and biotech customer, with options for additional work as programs advance.
- Teams will benchmark quantum optimization results against conventional statistical and machine-learning methods to assess where quantum adds value.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barclays significantly increased holdings in Tesla (TSLA.US) and Intel (INTC.US) in Q3, and bought Nasdaq ETF options for hedging
According to disclosures by the U.S. Securities and Exchange Commission (SEC), Barclays has submitted its third-quarter holdings report (13F) as of September 30, 2026.
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Crypto prices
More
